Exosome Hair Treatment: Next-Generation Stem Cell Approach 2026

From our previous website’s article collection. Dates, prices and treatment information reflect the original publication period.

PRP was long considered the "gold standard" in hair loss treatment. However, in recent years exosome technology has begun to enter the field of trichology, and early clinical data are promising. At Abel Beauty, we are among the clinics offering this treatment in the Izmit/Kocaeli region and consider it our priority to communicate its scientific basis transparently.

The Hair Growth Cycle: Essential Knowledge

Understanding the effects of exosomes requires knowledge of the hair growth cycle. Each follicle passes through three principal phases:

• Anagen (growth phase): The period during which hair actively grows. 85–90% of follicles on the scalp are in this phase. Duration: 2–6 years.
• Catagen (transition phase): A brief period during which the follicle shrinks and growth ceases. Duration: 2–3 weeks.
• Telogen (resting phase): The period during which the follicle is dormant and old hair is shed. Duration: 3–4 months.

The fundamental problem in androgenetic alopecia is the progressive shortening of the anagen phase under the influence of DHT (dihydrotestosterone). This process leads to miniaturisation (thinning) of the follicle and eventually to its death. Exosomes aim to reverse this process by prolonging the anagen phase.

Mechanism of Action of Exosomes on Hair Follicles

Exosomes reaching hair follicle stem cells specifically activate the Wnt/β-catenin signalling pathway. This pathway is the key biological switch that regulates the entry of the hair follicle into the anagen phase and its duration.

The effects of exosomes on the scalp:

• Stimulate proliferation of follicular stem cells (DP — dermal papilla cells)
• Help block the effect of DHT on the 5-alpha reductase enzyme
• Enhance scalp microcirculation (via VEGF)
• Suppress scalp inflammation — chronic inflammation accelerates follicle loss
• Increase follicle resistance to oxidative stress

Exosome Hair Treatment vs PRP Hair Treatment

Efficacy Findings for Androgenetic Alopecia

In a randomised controlled trial published in the Journal of Cosmetic Dermatology in 2024 (n=60, double-blind, placebo-controlled):

• The group receiving UC-MSC-derived exosome therapy showed a 35% increase in hair density after 3 sessions (measured by trichoscopy)
• 22% reduction in the telogen hair ratio (more hairs remained in the anagen phase)
• Average hair shaft diameter increased by +8 microns (reversal of hair thinning)
• Patient satisfaction scores significantly higher compared to the placebo group

These results are still early-stage data; large-scale long-term studies are ongoing. Head-to-head comparative studies with PRP began to be published during 2025–2026.

Combination Advantage with Finasteride

Finasteride is the gold standard in the medical treatment of androgenetic alopecia. When exosome therapy is used in combination with finasteride, a synergistic effect is expected:

• Finasteride slows follicle miniaturisation by reducing DHT production.
• Exosome therapy re-stimulates the growth capacity of follicles that are still active.
• Pilot studies using both together have reported a better response than with either alone.

Data on which patients benefit most from this combination are strengthening; the decision should be made together with a physician.

Treatment Protocol

The exosome hair treatment protocol applied at Abel Beauty:

1. Trichological assessment: Hair analysis (trichoscopy), dermatological examination and determination of alopecia type
2. Scalp cleansing: Removal of oil and product residues prior to the procedure
3. Topical anaesthesia: Pain minimisation with EMLA cream or a cooling device
4. Mesotherapy/micro-injection: Exosome preparation is injected into the scalp at 1–2 cm intervals
5. Post-procedure: Scalp massage (to increase microcirculation); no hair washing for 24 hours

Total session duration is approximately 45–60 minutes. Recommended protocol: 3–4 sessions, 4 weeks apart. Maintenance session: 1–2 times per year.

Who Is This Treatment Recommended For?

• Early-to-mid stage androgenetic alopecia (Hamilton-Norwood Stage I–IV, Ludwig Stage I–II)
• Telogen effluvium (periods of chronic hair loss)
• Patients who have not responded adequately to PRP
• Patients in whom PRP cannot be administered due to anaemia or thrombocytopenia
• Those wishing to strengthen follicle health in preparation for a hair transplant
• Those wishing to accelerate recovery and support the donor area after a hair transplant

Use of Exosomes in the Pre-Hair Transplant Preparation Process

Applying a 3-month exosome protocol prior to hair transplantation offers two advantages: scalp microcirculation and tissue quality improve, which may increase graft survival rates. At the same time, weak, miniaturised follicles in the recipient area may be revitalised, potentially reducing the area requiring transplantation. Exosome sessions commenced 4–6 weeks after hair transplantation also support graft recovery.

Contraindications and Points to Note

• Active scalp infection or dermatitis
• Pregnant and breastfeeding women (insufficient safety data)
• Active autoimmune disease flare
• Active psoriasis on the scalp
• Preparations produced from unverified donor sources (product safety is critical)

This article is for informational purposes only. Please consult a qualified physician for treatment decisions.